UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                  SCHEDULE 13D

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (AMENDMENT NO.23 )*

                             Meris Laboratories Inc.
                                (Name of Issuer)

                                  Common Stock
                         (Title of Class of Securities)

                                    589848100
                                 (CUSIP Number)

 JoAnn M. Strasser, Esq., Brown, Cummins, & Brown Co., L.P.A., 3500 Carew Tower,
             441 Vine Street, Cincinnati, Ohio 45202 (513) 381-2121
   (Name, Address and Telephone Number of Person Authorized to Receive Notices
                               and Communications)

                                     9/4/97
             (Date of Event which Requires Filing of this Statement)

           If the filing person has  previously  filed a statement on Schedule G
to report the acquisition which is the subject of this Schedule D, and is filing
this schedule because of Rule 13d-1(b) (3) or (4), check the following box.[  ]
  
           The  remainder  of this  cover  shall be filled  out for a  reporting
person's  initial  filing on this  form with  respect  to the  subject  class of
securities, and for any subsquenent amendment containing information which would
alter the disclosures provided in a prior cover page.

           The  information  required on the  remainder of this cover page shall
not be deemed to be "filed"  for the  purpose  of  Section 18 of the  Securities
Exchange  Act of 1934 ("Act") or otherwise  subject to the  liabilities  of that
section  of the Act but  shall be  subject  to all other  provisions  of the Act
(however, see the Notes).

1.NAME OF REPORTING PERSON
  S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
           Morton H. Sachs

2.CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*         (A)
                                                            (B) X
3.SEC USE ONLY

4.SOURCE OF FUNDS
           PF;OO

5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) OR 2(e) [ ]

6.CITIZENSHIP OR PLACE OF ORGANIZATION
           U.S.







NUMBER OF                7.  SOLE VOTING POWER                      815,000
SHARES
BENEFICIALLY             8.  SHARED VOTING POWER                          0
OWNED BY
EACH                     9.  SOLE DISPOSITIVE POWER                 815,000
REPORTING PERSON
WITH                     10. SHARED DISPOSITIVE POWER                     0

11.    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
           815,000

12.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
           [  ]

13.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
           10.2%

14.   TYPE OF REPORTING PERSON*
           IN

                                       13D
                             Additional Information
Item # 1.(a) Name of Issuer:
           Meris Laboratories Inc.

   (b) Address of Issuer's Principal Executive Offices:
           110 Summit Avenue
           P.O. Box 460
           Montvale, NJ 07645

2.(a) Name of Person Filing:
           Morton H. Sachs
  (b) Address of Principal Business Office for Each of the Above:
           1346 South Third Street
           Louisville, KY  40208
  (c) Principal Occupation
           Investment Adviser
  (d) No
  (e) No
  (f) Citizenship:
           United States

3. Source and Amount of Funds or Other Consideration:
           Reporting  Person disclaims  beneficial  ownership of 505,000 shares,
which represents the shares beneficially owned by the advisory clients of Morton
H. Sachs & Company dba The Sachs Company (the "Disclaimed Shares").

           Shares owned  directly by the Reporting  Person were  purchased  with
personal funds and amounted to $800.00.


4.Purpose of the Transaction:
           N/A

   5.Interest in Securities of the Issurer:
  (a) Reporting  person  may be deemed to  beneficially  own  815,000  shares of
common stock, representing 10.2% of the outstanding stock of the Issuer.





   (b) Reporting Person has sole  power to vote or to direct the vote,  and sole
power to dispose or to direct the disposition of such Reporting  person's shares
of the Issurer's stock.

   (c) See list below of transactions affecting beneficial ownership for Morton
H. Sachs:
                                      PRICE                   TRADE
              TRADE                   PER        TOTAL       AFFECTED
              DATE       SHARES      SHARE       COST        THROUGH
              ----       ------      -----       ----        -------
PURCHASES:
             9/3/97       10,000       .080      800.00      LEGG MASON


SALES:                                          TOTAL
                                               PROCEEDS
                                               --------
             8/25/97      10,000       0.030     299.99      LEGG MASON
             8/25/97      20,000       0.030     599.98      LEGG MASON
             9/2/97       30,000       0.043    1299.95      MAXUS SECURITIES
             9/4/97       10,000       0.050     499.98      MAXUS SECURITIES
             9/4/97       10,000       0.050     499.98      MAXUS SECURITIES
             9/4/97       10,000       0.050     499.99      MAXUS SECURITIES


  (D) WITH RESPECT TO THE DISCLAIMED SHARES,  EACH ADVISORY CLIENT HAS THE RIGHT
TO RECEIVE DIVIDENDS FROM, AND PROCEEDS FROM THE SALE OF, ITS RESPECTIVE SHARES.

  (E) N/A

6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSURER:
           REPORTING  PERSON  HAS  ENTERED  INTO  NO  CONTRACTS,   ARRANGEMENTS,
UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.

7.  MATERIALS TO BE FILED AS EXHIBITS
           NONE

REPORTING  PERSON  DISCLAIMS  BENEFICIAL  OWNERSHIP  OF  505,000  SHARES,  WHICH
REPRESENTS THE SHARES BENEFICIALLY OWNED BY THE ADVISORY CLIENTS OF MORTON H.
SACHS & COMPANY DBA THE SACHS COMPANY.

           AFTER  REASONABLE  INQUIRY  AND TO  THE  BEST  OF  THE  UNDERSIGNED'S
KNOWLEDGE AND BELIEF,  THE UNDERSIGNED  CERTIFIES THAT THE INFORMATION SET FORTH
IN THIS STATEMENT IS TRUE, COMPLETE AND CORRECT.


DATED AS OF    SEPTEMBER 4, 1997           SIGNATURE BY: /s/ MORTON H. SACHS
- --------------------------------                         -------------------
DATED ON:      DECEMBER 11, 1997                         MORTON H. SACHS
- --------------------------------                         -------------------